UMBC Logo OTD Web Page Header

Button-About OTD
Button-Technologies Available
Button-Reporting an Invention
Button-Policies
Button-Agreements and Forms
Button-Tech. Transfer Resources
Button-Information for Faculty
Button-Contact OTD





[Advanced Search]

[HOME]

 


Inventions Available for Licensing



Therapeutics
.
.
Ref. #: 1224DC
S-N-Hydroxy N-Methyl Carbamoyl Glutathione [glycyl]-0-
ethyl Ester
.
This invention is a novel chemotherapeutic approach to cancer treatment
that is based on a metabolic pathway that is dramatically different between .
cancer cells and normal cells has been proposed. The method involves
inducing higher steady-state concentrations of cytotoxic methylglyoxal by
inhibiting the enzymes that catalyze the conversion of methylglyoxal to D-
lactate.
.
Issued US Patents:
.
5,616,563 4 /1 /1997
Glutathione N-Hydroxycarbamoyl Thioesters and Method of Inhibiting
Neoplastic Growth
.
.
Ref. #: 2202JR
Collagen and Flexible Polymer Drug Delivery Device
.
This invention is a highly concentrated solution of negatively charged
collagen molecules and a negatively charged flexible polymer at neutral pH. .
The principle feature of this invention is that the combination or mixture of
rigid-rod collagen and flexible coil polymers gives unique benefits in
controlling the release of protein drugs.
Rigid polymers, such as collagen, tend to reduce diffusion rates more
effectively than flexible polymers when mesh sizes are similar, while flexible
polymers, which have much smaller mesh sizes, can fill mesh spaces more
effectively than rigid polymers when they are concentrated.
.
Issued US Patents:
.
5,928,667 7 /27/1999
Drug Delivery Device and Method for Employing the Same
.

Page 1 of 4